Abstract
BACKGROUND The role of dairy products in the primary prevention of cardiovascular disease (CVD) remains highly debated. Our study aimed to comprehensively evaluate the association between dairy consumption and CVD risk in Eastern and Western countries.
METHODS Cohort analyses include 487 212 individuals from the China Kadoorie Biobank (CKB) and 418 895 individuals from the UK Biobank (UKB). Dairy consumption was assessed by validated food frequency questionnaires. We calculated hazard ratios using multivariable Cox proportional-hazards models. The primary outcome was incident CVD, coronary heart disease (CHD) and stroke. An updated meta-analysis of prospective cohort studies was further conducted.
RESULTS A total of 98 954 CVD cases occurred during a mean follow-up of 8.6 years in CKB and 11.3 years in UKB. In CKB, regular dairy consumption (mainly liquid whole milk) was not associated with CVD risk but significantly associated with a 9% (95% confidence interval [CI], 5% to 13%) higher CHD risk and a 6% (95% CI, 3% to 9%) lower stroke risk compared with non/rare consumers. In UKB, total dairy consumption was associated with lower risk of CVD, CHD and ischemic stroke. Cheese consumption was associated with lower CVD risk. Multivariable-adjusted hazard ratios (HRs) (95% CIs) comparing ≥ 7 times/week to the < 2 times/week of cheese were 0.88 (0.83–0.94) for CVD, 0.88 (0.82–0.94) for CHD, and 0.97 (0.85–1.11) for stroke. Semi-skimmed milk consumers had decreased risk of CVD and stroke. In the updated meta-analysis, total dairy consumption was significantly associated with a lower risk of CVD (relative risk [RR], 0.963; 95% CI, 0.932 to 0.995; 26 risk estimates) and stroke (RR, 0.94; 95% CI, 0.90 to 0.98; 14 risk estimates). Inverse associations with CVD incidence were found for cheese (0.94; 0.91 to 0.97; 20 risk estimates) and low-fat dairy (0.96; 0.92 to 0.99; 20 risk estimates) but not milk and yogurt.
CONCLUSIONS Total dairy consumption is associated with a lower risk of total CVD and stroke overall but relationships vary by types of dairy products. Cheese and low-fat dairy consumption may be advocated for the primary prevention of CVD.
What Is New?
Whether dairy products are protective for cardiovascular disease (CVD) remains highly debated.
This global largest analysis that included two original cohorts of 0.9 million participants from China and the UK and an updated meta-analysis demonstrates that higher consumption of total dairy products was associated with lower risk of CVD and stroke overall.
For dairy subtypes, cheese and low-fat dairy consumption was associated with lower CVD risk while no significant association was observed for milk, yogurt, and high-fat dairy consumption.
What Are the Clinical Implications?
Results from our two large cohort studies and updated meta-analysis support that dairy product consumption is protective for CVD, especially stroke, and provide compelling evidence relevant to dietary guidelines.
Considering specific dairy subtypes, cheese, and low-fat dairy products may be protective and should be advocated for CVD prevention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Key Research and Development Program of China (grant no. 2017YFC1600500), China National Program for Support of Top-notch Young Professionals, and China Postdoctoral Science Foundation (grant no. 2022T150577).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank received ethical approval from the research ethics committee (REC reference for UK Biobank 11/NW/0382).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The UK Biobank data are available from the UK Biobank on request (www.ukbiobank.ac.uk/). Details of how to access China Kadoorie Biobank data and details of the data release schedule are available from www.ckbiobank.org/site/Data+Access.
Nonstandard Abbreviations and Acronyms
- BMI
- body mass index
- CHD
- coronary heart disease
- CI
- confidence interval
- CKB
- China Kadoorie Biobank
- CRP
- C-reactive protein
- CVD
- cardiovascular disease
- FFQ
- food frequency questionnaire
- HDL
- high-density lipoprotein
- HR
- hazard ratios
- LDL
- low-density lipoprotein
- RR
- relative risk
- SFA
- saturated fatty acids
- TDI
- Townsend deprivation index
- UKB
- UK Biobank.
